Sanofi pulls out of Dagenham
December 21, 2009Manufacturing and Production Essex, Sanofi, closure
The UK stands to lose one of its flagship pharmaceutical manufacturing facilities with the recent announcement that Sanofi-Aventis’ site in …
Sanofi’s Plavix combination recommended for European approval
December 21, 2009Research and Development, Sales and Marketing DuoPlavin, Plavix, Sanofi, cabazitaxel, eplivanserin, idrabiotaparinux
Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …
Digital Pharma: Roche tackles sidewiki
December 21, 2009Medical Communications Roche, digi, digital pharma, google, sidewiki
Roche has become the second pharma company to tackle sidewiki on its corporate website, posting an entry that sets out …
Dr Michael Rosenblatt appointed chief medical officer Merck
December 21, 2009Research and Development, Sales and Marketing Dr Michael Rosenblatt, Merck & Co, appointment, appointments, research and development, sales and marketing
Merck & Co. appoints Dr Michael Rosenblatt executive VP and chief medical officer. He will be the company’s primary voice …
Merck buys Avecia to boost biomanufacturing
December 21, 2009Manufacturing and Production, Research and Development Avecia Biologics, Cobra, Merck & Co, Recipharm
Merck & Co has bolstered its capabilities in biologics production with the acquisition of contract manufacturer Avecia Biologics. The deal …
Time-sensitive shipments go further
December 18, 2009Manufacturing and Production
The logistical challenges of transporting clinical trials samples over long distances arerapidly being overcome, says Sue Lee, Manager of Biopharm …
Chiltern Announces Collaboration with Dr Nawab Qizilbash
December 18, 2009Research and Development
Dr Nawab Qizilbash, MBChB BSc MRCP (UK) MSc Phil (Oxon) is the Director of OXON Epidemiology Ltd. He served as …
Boehringer’s ovarian cancer drug enters phase III
December 18, 2009Research and Development, Sales and Marketing Boehringer, Cancer, ovarian
Boehringer Ingelheim has started a new phase III trial for its investigational cancer drug BIBF 1120. The LUME-Ovar-1 programme will …
UK supports stem cell research with online toolkit
December 18, 2009Research and Development ReNeuron, regenerative medicine, stell cell
A new online resource has been launched to help stem cell researchers in the UK plan a regulatory route for …
Sir Liam Donaldson steps down as England’s chief medical officer
December 18, 2009Liam Donaldson, NHS, UK, appointment
England’s chief medical officer Sir Liam Donaldson will step down in May 2010 after 12 years of service. Details for …
ScopeMedical boosts digital offering
December 18, 2009Medical Communications ScopeMedical, digi
Kent-based med ed agency ScopeMedical has boosted its in-house digital offering and says there are plans to grow it further …
Hospira buys Orchid generic injectables business for $400m
December 18, 2009Manufacturing and Production Hospira, India, Orchid, injectables
Indian active pharmaceutical ingredient manufacturer Orchid Chemicals & Pharmaceuticals has signed a $400 million deal to sell the assets of …
NICE still saying ‘no’ to Roche’s RoActemra
December 17, 2009Sales and Marketing NICE, RoActemra, Roche
Roche will have to present a stronger case for arthritis drug RoActemra in order to gain approval, according to NICE. …
ICON investments will come to fruition in 2010
December 16, 2009Research and Development ICON, Manchester, translational
Irish contract research organisation ICON has provided additional details on its new translational medicine unit in Manchester, UK, first announced …
Digital Pharma: A Year in Digital (5/5)
December 16, 2009Medical Communications 2009, Boehringer, digi, digital pharma, year in review
Favourite use of digital (pharma)• Microsoft’s future of healthcare video. It’s their vision of the possibilities that I fell in …
GSK signs needle-free vaccine alliance
December 16, 2009Research and Development, Sales and Marketing GlaxoSmithKline, Intercell, patch, vaccines
GlaxoSmithKline has signed a deal with Intercell to see whether any of its vaccines could be made available in patch …
Sanofi invests in syringe production in France
December 16, 2009Manufacturing and Production France, Sanofi-Aventis, vaccines
Sanofi-Aventis has doubled its capacity to manufacture syringe-delivered medicines with the opening of new production units at Le Trait, near …
Three new starters at ScopeMedical
December 16, 2009Medical Communications ScopeMedical, appointment, medical communications
ScopeMedical has appointed Toby Galbraith as account director, Carol Richter as medical writer and Chris Tilly as account manager.Toby has …
GSK discloses US healthcare professional payments
December 15, 2009Medical Communications GSK, doctors, industry reputation, payments
GlaxoSmithKline has disclosed some of the fees it has paid to US healthcare professionals for speaking and consulting services.The list …
Digital Pharma: A Year in Digital (4/5)
December 15, 2009Medical Communications 2009, Bayer, digi, digital pharma, year in review
Favourite use of digital (pharma)Physicians’ social networks. This is pharma’s new engagement channel offering the industry an opportunity to normalise …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
